RWA Wealth Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.01M | Sell |
11,603
-1,341
| -10% | -$128K | 0.01% | 346 |
|
|
2025
Q4 | $1.24M | Buy |
12,944
+585
| +5% | +$56.8K | 0.01% | 323 |
|
|
2025
Q3 | $1.18M | Buy |
12,359
+1,944
| +19% | +$179K | 0.01% | 325 |
|
|
2025
Q2 | $908K | Sell |
10,415
-63,812
| -86% | -$5.41M | 0.01% | 344 |
|
|
2025
Q1 | $6.67M | Buy |
74,227
+62,697
| +544% | +$5.61M | 0.08% | 129 |
|
|
2024
Q4 | $921K | Buy |
11,530
+1,352
| +13% | +$117K | 0.01% | 340 |
|
|
2024
Q3 | $916K | Buy |
10,178
+224
| +2% | +$18.8K | 0.01% | 336 |
|
|
2024
Q2 | $783K | Sell |
9,954
-1,270
| -11% | -$104K | 0.01% | 338 |
|
|
2024
Q1 | $978K | Sell |
11,224
-37
| -0.3% | -$3.16K | 0.01% | 308 |
|
|
2023
Q4 | $928K | Buy |
11,261
+5,174
| +85% | +$394K | 0.01% | 299 |
|
|
2023
Q3 | $477K | Sell |
6,087
-1
| -0% | -$84 | 0.01% | 272 |
|
|
2023
Q2 | $536K | Buy |
6,088
+1,520
| +33% | +$131K | 0.01% | 225 |
|
|
2023
Q1 | $368K | Sell |
4,568
-507
| -10% | -$41.3K | 0.01% | 193 |
|
|
2022
Q4 | $408K | Sell |
5,075
-91,646
| -95% | -$7.43M | 0.01% | 193 |
|
|
2022
Q3 | $7.81M | Buy |
96,721
+2,860
| +3% | +$257K | 0.55% | 40 |
|
|
2022
Q2 | $8.42M | Buy |
93,861
+3,792
| +4% | +$384K | 0.57% | 39 |
|
|
2022
Q1 | $9.99M | Buy |
90,069
+25,405
| +39% | +$2.68M | 0.65% | 37 |
|
|
2021
Q4 | $6.69M | Sell |
64,664
-9,338
| -13% | -$1.08M | 0.45% | 62 |
|
|
2021
Q3 | $9.28M | Buy |
74,002
+968
| +1% | +$125K | 0.69% | 39 |
|
|
2021
Q2 | $9.07M | Buy |
73,034
+1,790
| +3% | +$225K | 0.68% | 39 |
|
|
2021
Q1 | $8.42M | Buy |
71,244
+12,047
| +20% | +$1.41M | 0.68% | 42 |
|
|
2020
Q4 | $6.93M | Sell |
59,197
-246
| -0.4% | -$27.1K | 0.62% | 40 |
|
|
2020
Q3 | $6.18M | Buy |
59,443
+3,710
| +7% | +$373K | 0.65% | 40 |
|
|
2020
Q2 | $5.11M | Buy |
55,733
+6,124
| +12% | +$587K | 0.62% | 46 |
|
|
2020
Q1 | $4.47M | Sell |
49,609
-2,787
| -5% | -$297K | 0.63% | 41 |
|
|
2019
Q4 | $5.94M | Buy |
52,396
+1,086
| +2% | +$119K | 0.59% | 45 |
|
|
2019
Q3 | $5.57M | Sell |
51,310
-67
| -0.1% | -$6.99K | 0.59% | 44 |
|
|
2019
Q2 | $5M | Buy |
51,377
+19,841
| +63% | +$1.81M | 0.54% | 44 |
|
|
2019
Q1 | $2.87M | Buy |
+31,536
| New | +$2.82M | 0.33% | 77 |
|
|
2018
Q3 | – | Sell |
-26
| Closed | -$2K | – | 520 |
|
|
2018
Q2 | $2K | Sell |
26
-800
| -97% | -$66.8K | ﹤0.01% | 752 |
|
|
2018
Q1 | $66K | Buy |
+826
| New | +$68.1K | 0.01% | 309 |
|
|
2017
Q3 | – | Sell |
-2,264
| Closed | -$201K | – | 242 |
|
|
2017
Q2 | $201K | Buy |
+2,264
| New | +$191K | 0.02% | 181 |
|
Other funds holding MDT
VCM
VPM
RWA Wealth Partners's MDT Position: Q1 2026 in Review
RWA Wealth Partners reduced its Medtronic (MDT) stake by 10% in Q1 2026, selling an estimated $128K and leaving 11,603 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #346.
RWA Wealth Partners first reported a position in MDT in Q2 2017 and has held it in 32 quarters since. The position peaked at $9.99M in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- RWA Wealth Partners held 11,603 shares of Medtronic worth $1.01M as of Q1 2026.
- RWA Wealth Partners sold 1,341 Medtronic shares in Q1 2026, an estimated $128K.
- Medtronic made up 0.01% of RWA Wealth Partners's portfolio in Q1 2026, its #346 holding.
- RWA Wealth Partners first reported a position in Medtronic in Q2 2017 and has held it in 32 quarters since.
- RWA Wealth Partners's Medtronic position peaked at $9.99M in Q1 2022.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on RWA Wealth Partners's 13F filing for Q1 2026, filed 13 May 2026.